M1FG
UTHR icon

Mach-1 Financial Group’s United Therapeutics UTHR Stock Holding History

Mach-1 Financial Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,770
Closed -$1.08M – 403
2025
Q2 		$1.08M Buy
3,770
+1,217
+48% +$364K 0.32% 80
2025
Q1 		$787K Buy
+2,553
New +$875K 0.24% 107

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Mach-1 Financial Group's UTHR Position: Q3 2025 in Review

Mach-1 Financial Group sold out of United Therapeutics (UTHR) in Q3 2025, closing a stake of 3,770 shares — an estimated $1.08M sold.

Mach-1 Financial Group first reported a position in UTHR in Q1 2025 and held it in 2 quarters. The position peaked at $1.08M in Q2 2025. 708 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

  • Mach-1 Financial Group reported no remaining United Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Mach-1 Financial Group sold 3,770 United Therapeutics shares in Q3 2025, an estimated $1.08M.
  • Mach-1 Financial Group first reported a position in United Therapeutics in Q1 2025 and held it in 2 quarters.
  • Mach-1 Financial Group's United Therapeutics position peaked at $1.08M in Q2 2025.
  • 708 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on Mach-1 Financial Group's 13F filing for Q3 2025, filed 12 Nov 2025.